Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Abstract [18F]fluorodeoxyglucose (FDG) PET and [123I]metaiodobenzylguanidine (MIBG) scintigraphy may contribute to the differential diagnosis of neurodegenerative parkinsonism. To identify the superior method, we retrospectively evaluated 54 patients with suspected neurodegenerative parkinsonism, wh...
Guardado en:
Autores principales: | Joachim Brumberg, Nils Schröter, Ganna Blazhenets, Lars Frings, Jens Volkmann, Constantin Lapa, Wolfgang H. Jost, Ioannis U. Isaias, Philipp T. Meyer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76f2b64fc9244ade9b5595d1f9784421 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas
por: Thomas M. Stadler, et al.
Publicado: (2020) -
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
por: Jeanette Ansholm Hansen, et al.
Publicado: (2021) -
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
por: Jeanette Ansholm Hansen, et al.
Publicado: (2021) -
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study.
por: Yoichi Sawada, et al.
Publicado: (2012) -
[18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species
por: Naoko Nose, et al.
Publicado: (2021)